Cold weather may bring more than just a chill—some people experience allergic reactions triggered by exposure to cold ...

Enter food therapy—a gentle, empowering approach that harnesses the power of everyday edibles to address root causes like ...

Tirzepatide users on hormone therapy had added improvements in weight, cardiometabolic mar ...

Rebecca Nako, 51, said she was shocked to learn that her daughter Winifred, then seven, had been diagnosed with Kawasaki ...

The star of the acquisition, anti-IgE antibody ozureprubart, is being tested as a prophylactic treatment for food allergies, ...

Anaphylaxis triggered by iodinated contrast media was rare, but severe and refractory cases indicated the need for ...

A lack of understanding about what scabies is and how it’s treated could be behind the United Kingdom’s sudden spike in cases ...

RAPT Therapeutics, Inc. is being acquired by GSK plc for $2.2B as ozureprubart targets IgE disorders with 8–12 week dosing.

GSK acquires Rapt Therapeutics for $2.2B. Stock surges 65% as pharma giant gains access to phase 2b food allergy treatment ...

That price equates to an aggregate equity value of $2.2 billion, according to GSK, who added that the upfront investment net ...

The bass player and singer on naming his chickens, selling his Banksy and surviving cancer ...

A 58-year-old woman was admitted to the hospital 3 weeks after lumbar surgery because of diplopia and fever. Left leg pain and a rash had preceded the fever and diplopia. A diagnosis was made.